A Two-Part Model of the Individual Costs of Chronic Kidney Disease

References

• Bentley, T. S., and N. J. Ortner. 2020. 2020 U.S. organ and tissue transplants: Cost estimates, discussion, and emerging issues. Technical report, Milliman Research Report.
   Google Scholar
• Centers for Disease Control and Prevention. 2021. Chronic kidney disease, common, serious, costly. https://www.cdc.gov/kidneydisease/pdf/CKD-common-serious-costly-h.pdf
   Google Scholar
• Centers for Medicare and Medicaid Services. 2021. End stage renal disease (ESRD). https://www.cms.gov/Medicare/Coordination-of-Bene_ts-and-Recovery/Coordination-of-Bene_ts-and-Recovery-Overview/End-Stage-Renal-Disease-ESRD/ESRD
   Google Scholar
• Chang, Y.-T., J.-S. Hwang, S.-Y. Hung, M.-S. Tsai, J.-L. Wu, J.-M. Sung, and J.-D. Wang. 2016. Cost-effectiveness of hemodialysis and peritoneal dialysis: A national cohort study with 14 years follow-up and matched for comorbidities and propensity score. Scientific Reports 6:30266.
   PubMed Web of Science ®Google Scholar
• Chen, P. M., T. S. Lai, P. Y. Chen, C. F. Lai, S. Y. Yang, V. Wu, C. K. Chiang, T. W. Kao, J. W. Huang, W. C. Chiang, et al. 2015. Multidisciplinary care program for advanced chronic kidney disease: Reduces renal replacement and medical costs. American Journal of Medicine 128 (1):68–76.
   PubMed Web of Science ®Google Scholar
• Chen, T., and C. Guestrin. 2016. Xgboost: A scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, 785–94.
   Google Scholar
• Chen, T., T. He, M. Benesty, and V. Khotilovich. 2019. Package XGBoost, R version 90.
   Google Scholar
• Chen, T., T. He, M. Benesty, V. Khotilovich, Y. Tang, H. Cho, K. Chen, R. Mitchell, I. Cano, T. Zhou, et al. 2015. XGBoost: Extreme gradient boosting. R Package Version 0.4-2 1 (4):1–4.
   Google Scholar
• Collins, A. J., R. N. Foley, C. Herzog, B. M. Chavers, D. Gilbertson, A. Ishani, B. L. Kasiske, J. Liu, L.-W. Mau, M. McBean, et al. 2010. Excerpts from the U.S. Renal Data System 2009 annual data report. American Journal of Kidney Diseases 55 (1):A6–7.
   Web of Science ®Google Scholar
• Damien, P., H. J. Lanham, M. Parthasarathy, and N. L. Shah. 2016. Assessing key cost drivers associated with caring for chronic kidney disease patients. BMC Health Services Research 16 (1):1–10.
   PubMedGoogle Scholar
• Drawz, P., T. H. Hostetter, and M. E. Rosenberg. 2020. Slowing progression of chronic kidney disease. In Chronic renal disease, eds. P. L. Kimmel and M. E. Rosenberg, 937–59. Academic Press. doi:10.1016/B978-0-12-815876-0.00057-7.
   Google Scholar
• Drawz, P. E., and M. E. Rosenberg. 2013. Slowing progression of chronic kidney disease. Kidney International Supplements 3 (4):372–76.
   Web of Science ®Google Scholar
• Erickson, K. F., S. Japa, D. K. Owens, G. M. Chertow, A. M. Garber, and J. D. Goldhaber-Fiebert. 2013. Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. Journal of the American College of Cardiology 61 (12):1250–58.
   PubMed Web of Science ®Google Scholar
• Fricks, R. B., A. Bobbio, and K. S. Trivedi. 2016. Reliability models of chronic kidney disease. Paper presented at the 2016 Annual Reliability and Maintainability Symposium (RAMS), Tucson, AZ, USA, January 25–28.
   Google Scholar
• Gandjour, A., W. Armsen, W. Wehmeyer, J. Multmeier, and U. Tschulena. 2020. Costs of patients with chronic kidney disease in Germany. PloS ONE 15 (4):e0231375.
   PubMed Web of Science ®Google Scholar
• Golestaneh, L., P. J. Alvarez, N. L. Reaven, S. E. Funk, K. J. McGaughey, A. Romero, M. S. Brenner, and M. Onuigbo. 2017. All-cause costs increase exponentially with increased chronic kidney disease stage. American Journal of Managed Care 23 (10 Suppl):S163–S72.
   PubMed Web of Science ®Google Scholar
• Hoerger, T. J., J. S. Wittenborn, J. E. Segel, N. R. Burrows, K. Imai, P. Eggers, M. E. Pavkov, R. Jordan, S. M. Hailpern, A. C. Schoolwerth, et al. 2010a. A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences. American Journal of Kidney Diseases 55 (3):452–62.
   PubMed Web of Science ®Google Scholar
• Hoerger, T. J., J. S. Wittenborn, J. E. Segel, N. R. Burrows, K. Imai, P. Eggers, M. E. Pavkov, R. Jordan, S. M. Hailpern, A. C. Schoolwerth, et al. 2010b. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. American Journal of Kidney Diseases 55 (3):463–73.
   PubMed Web of Science ®Google Scholar
• Honeycutt, A. A., J. E. Segel, X. Zhuo, T. J. Hoerger, K. Imai, and D. Williams. 2013. Medical costs of CKD in the Medicare population. Journal of the American Society of Nephrology 24 (9):1478–83.
   PubMed Web of Science ®Google Scholar
• Hopkins, R. B., A. X. Garg, A. Levin, A. Molzahn, C. Rigatto, J. Singer, G. Soltys, S. Soroka, P. S. Parfrey, B. J. Barrett, et al. 2011. Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease. Clinical Journal of the American Society of Nephrology 6 (6):1248–57.
   PubMed Web of Science ®Google Scholar
• Johnson, C. A., A. S. Levey, J. Coresh, A. Levin, and J. G. L. Eknoyan. 2004. Clinical practice guidelines for chronic kidney disease in adults: Part 1. Definition, disease stages, evaluation, treatment, and risk factors. American Family Physician 70 (5):869–76.
   PubMed Web of Science ®Google Scholar
• Kerr, M., B. Bray, J. Medcalf, D. J. O’Donoghue, and B. Matthews. 2012. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrology Dialysis Transplantation 27 (Suppl 3):iii73–80.
   PubMed Web of Science ®Google Scholar
• Khan, S., and C. A. Amedia Jr. 2008. Economic burden of chronic kidney disease. Journal of Evaluation in Clinical Practice 14 (3):422–34.
   PubMed Web of Science ®Google Scholar
• Kirchhoff, S. M. 2018. Medicare coverage of end-stage renal disease (ESRD). Report R45290, Congressional Research Service, Washington, DC.
   Google Scholar
• Kondo, M., K. Yamagata, S.-L. Hoshi, C. Saito, K. Asahi, T. Moriyama, K. Tsuruya, H. Yoshida, K. Iseki, and T. Watanabe. 2012. Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clinical and Experimental Nephrology 16 (2):279–91.
   PubMed Web of Science ®Google Scholar
• Laliberté, F., B. K. Bookhart, F. Vekeman, M. Corral, M. S. Duh, R. A. Bailey, C. T. Piech, and P. Lefebvre. 2009. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: A managed care perspective. Journal of Managed Care Pharmacy 15 (4):312–22.
   PubMed Web of Science ®Google Scholar
• Levey, A. S., C. Becker, and L. A. Inker. 2015. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: A systematic review. Journal of the American Medical Association 313 (8):837–46.
   PubMed Web of Science ®Google Scholar
• Levey, A. S., and J. Coresh. 2012. Chronic kidney disease. The Lancet 379 (9811):165–80.
   PubMed Web of Science ®Google Scholar
• Manns, B., B. Hemmelgarn, M. Tonelli, F. Au, T. C. Chiasson, J. Dong, and S. Klarenbach. 2010. Population based screening for chronic kidney disease: Cost effectiveness study. BMJ British Medical Journal 341:c5869.
   Web of Science ®Google Scholar
• Manns, B., B. Hemmelgarn, M. Tonelli, F. Au, H. So, R. Weaver, A. E. Quinn, and S. Klarenbach, for Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease. 2019. The cost of care for people with chronic kidney disease. Canadian Journal of Kidney Health and Disease 6. doi:10.1177/2054358119835521.
   Google Scholar
• National Institutes of Health. 2021. Slow progression & reduce complications. https://www.niddk.nih.gov/health-information/professionals/clinical-tools-patient-management/kidney-disease/identify-manage-patients/manage-ckd/slow-progression-reduce-complications
   Google Scholar
• Orlando, L. A., E. J. Belasco, U. D. Patel, and D. B. Matchar. 2011. The chronic kidney disease model: A general purpose model of disease progression and treatment. BMC Medical Informatics and Decision Making 11 (1):41.
   PubMedGoogle Scholar
• Saran, R., A. Pearson, A. Tilea, V. Shahinian, J. Bragg-Gresham, M. Heung, D. W. Hutton, D. Steffick, K. Zheng, H. Morgenstern, et al. 2021. Burden and cost of caring for US veterans with CKD: initial findings from the VA Renal Information System (VA-REINS). American Journal of Kidney Diseases 77 (3):397–405.
   PubMed Web of Science ®Google Scholar
• Tangri, N., L. A. Stevens, J. Griffith, H. Tighiouart, O. Djurdjev, D. Naimark, A. Levin, and A. S. Levey. 2011. A predictive model for progression of chronic kidney disease to kidney failure. Journal of the American Medical Association 305 (15):1553–59.
   PubMed Web of Science ®Google Scholar
• Tibshirani, R. 1996. Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society: Series B (Methodological) 58 (1):267–88.
   Web of Science ®Google Scholar
• Waldorf, B., and A. Kim. 2018. The index of relative rurality (IRR): U.S. county data for 2000 and 2010. https://purr.purdue.edu/publications/2960/1
   Google Scholar
• Wei, S.-Y., Y.-Y. Chang, L.-W. Mau, M.-Y. Lin, H.-C. Chiu, J.-C. Tsai, C.-J. Huang, H.-C. Chen, and S.-J. Hwang. 2010. Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs. Nephrology 15 (1):108–15.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). 1993. The ICD-10 classification of mental and behavioural disorders. World Health Organization.
   Google Scholar
• World Health Organization. 2019. International statistical classification of diseases and related health problems (11th ed.). https://icd.who.int
   Google Scholar